VTYX
Ventyx Biosciences Inc
NASDAQ: VTYX · HEALTHCARE · BIOTECHNOLOGY
$14.00
+0.00% today
Updated 2026-03-04
Market cap
$1.00B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.49
Dividend yield
—
52W range
$1 – $15
Volume
4.1M
Ventyx Biosciences Inc (VTYX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-0.45%
ROA
-0.29%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-4.47M | — | — | — |
| 2020 | $0.00 | $-28.17M | — | — | — |
| 2021 | $0.00 | $-83.75M | — | — | — |
| 2022 | $0.00 | $-108.43M | — | — | — |
| 2023 | $0.00 | $-192.96M | — | — | — |
| 2024 | $0.00 | $-135.12M | — | — | — |